Two Late-Line Drugs Offer Equal Survival in Metastatic Colorectal Cancer, Landmark Study Finds
A large prospective Japanese study found that late-line treatment sequences beginning with either regorafenib or trifluridine/tipiracil plus bevacizumab yielded comparable ...
